IC50
- Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor (02 Sep 2024)
- Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy (01 Sep 2022)
- Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)